BioAffinity Technologies Secures Patent for Novel Cancer Therapy Targeting CD320 and LRP2 Receptors
On Wednesday, BioAffinity Technologies Inc. (NASDAQ:BIAF) announced that the US Patent and Trademark Office/USPTO has issued a new patent.
Bioaffinity Technologies Inc. (BIAF)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 6,802.7,333,333,333 | $26,531 | 0% | ||
| 2. | 1,078.5 | $4,206 | -11% | 0% | |
| 3. | Sprott Asset Management Eric Sprott | 333.33,333,333,333 | $2,872 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 8,163 | $0.00 | 22,448 | 2022-08-31 | Filing | |
| $0.00 | 4,081 | $0.00 | 4,081 | 2022-08-31 | Filing | |
| $0.00 | 4,081 | $0.00 | 4,081 | 2022-08-31 | Filing | |
| $0.00 | 2,448 | $0.00 | 30,323 | 2022-09-01 | Filing | |
| $0.00 | 16,326 | $0.00 | 19,897 | 2022-08-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,181.9,666,666,667 | $36,031 | 0% | |
| 2. | 1,791.1,333,333,333 | $15,433 | 0% | |
| 3. | 1,354.7,333,333,333 | $11,664 | 0% | |
| 4. | 929.5 | $8,009 | 0% | |
| 5. | 833.33,333,333,333 | $7,180 | 0% |
News See All
